HIRTH-DIETRICH, CLAUDIA,SANDNER, PETER,STASCH, JOHANNES-PETER,KNORR, ANDREAS,VON DEGENFELD, GEORGES,HAHN, MICHAEL,FOLLMANN, MARKUS
申请号:
PL11722786
公开号:
PL2576548T3
申请日:
2011.05.24
申请国别(地区):
PL
年份:
2015
代理人:
摘要:
The use of sGC stimulators, sGC activators alone, or in combination with PDE5 inhibitors for the prevention and treatment of fibrotic diseases, such as systemic sclerosis, scleroderma, and the concomitant fibrosis of internal organs.